Cancer Treatment Centers of America | Strategic Alliance Partners

Latest from Cancer Treatment Centers of America

PFS Deserves More Than Surrogate Status as a Clinical Trial End Point

January 20, 2021

Although recent benefits do not pertain to all cancers and “cure” remains a relatively uncommon event, oncologists have an increasing number of molecularly targeted and immunotherapeutic strategies to employ based on objectively meaningful clinical trial outcomes.

Markman: COVID-19 Takes Science on a Roller-Coaster Ride

January 10, 2021

In a pandemic, the public and its leaders yearn for relatively simple answers that can lead to solutions and forceful actions such as preventing serious infection and hospitalizations, treating active illness, and developing safe and effective vaccines quickly made available to the public.

Pandemic Heightens Stress of Cancer Diagnosis

December 01, 2020

The repercussions of delays in diagnosing cancer, either through screening or the presence of early symptoms, and of required modifications in standard-of-care management paradigms in the COVID-19 era are only now beginning to be fully appreciated.

Old-Fashioned Biology Trumps Technological Potential

April 10, 2019

The recent technological advances in medicine and related fields have encouraged a belief among many that there is little technology will not be able to accomplish in improving cancer-related clinical outcomes, but it must be acknowledged that clinical medicine and cancer biology are extremely complex arenas.